GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,405.50p
   
  • Change Today:
      10.50p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,090.14m
  • Volume: 4,871,527
  • Market Cap: £57,487m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
3.08% below the market average3.08% below the market average3.08% below the market average3.08% below the market average3.08% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr Revenue Growth
0.66% below the market average0.66% below the market average0.66% below the market average0.66% below the market average0.66% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
24.44% above the market average24.44% above the market average24.44% above the market average24.44% above the market average24.44% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
6.25% above the market average6.25% above the market average6.25% above the market average6.25% above the market average6.25% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
10.93% below the market average10.93% below the market average10.93% below the market average10.93% below the market average10.93% below the market average
61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average
Price Book Ratio
73.45% below the market average73.45% below the market average73.45% below the market average73.45% below the market average73.45% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
54.11% below the market average54.11% below the market average54.11% below the market average54.11% below the market average54.11% below the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Price Chg 3m
55.16% below the market average55.16% below the market average55.16% below the market average55.16% below the market average55.16% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
44.82% below the market average44.82% below the market average44.82% below the market average44.82% below the market average44.82% below the market average
9.52% below the sector average9.52% below the sector average9.52% below the sector average9.52% below the sector average9.52% below the sector average
Momentum 20
96.79% below the market average96.79% below the market average96.79% below the market average96.79% below the market average96.79% below the market average
80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
17.27% above the market average17.27% above the market average17.27% above the market average17.27% above the market average17.27% above the market average
68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average
ROCE
68.41% above the market average68.41% above the market average68.41% above the market average68.41% above the market average68.41% above the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
90.76% above the market average90.76% above the market average90.76% above the market average90.76% above the market average90.76% above the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average
Forecast EPS
79.55% above the market average79.55% above the market average79.55% above the market average79.55% above the market average79.55% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.82% above the market average97.82% above the market average97.82% above the market average97.82% above the market average97.82% above the market average
93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average
Operating Profit Loss
97.93% above the market average97.93% above the market average97.93% above the market average97.93% above the market average97.93% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.20% above the market average97.20% above the market average97.20% above the market average97.20% above the market average97.20% above the market average
95.35% above the sector average95.35% above the sector average95.35% above the sector average95.35% above the sector average95.35% above the sector average
Cash
96.82% above the market average96.82% above the market average96.82% above the market average96.82% above the market average96.82% above the market average
95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
75.96% above the market average75.96% above the market average75.96% above the market average75.96% above the market average75.96% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Buys 1y
99.33% above the market average99.33% above the market average99.33% above the market average99.33% above the market average99.33% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
91.25% below the market average91.25% below the market average91.25% below the market average91.25% below the market average91.25% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
83.13% above the market average83.13% above the market average83.13% above the market average83.13% above the market average83.13% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,405.50p
Change Today 10.50p
% Change 0.75 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 4,871,527
Shares Issued 4,090.14m
Market Cap £57,487m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.44% below the market average46.44% below the market average46.44% below the market average46.44% below the market average46.44% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Trend
1.59% above the market average1.59% above the market average1.59% above the market average1.59% above the market average1.59% above the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Income
75.27% above the market average75.27% above the market average75.27% above the market average75.27% above the market average75.27% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
32.97% below the market average32.97% below the market average32.97% below the market average32.97% below the market average32.97% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 27-Jun-2025

Time Volume / Share Price
16:13 0 @ 1,404.00p
16:13 0 @ 1,404.00p
16:13 0 @ 1,404.00p
16:13 1 @ 1,404.00p
16:13 0 @ 1,404.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page